Experimental and Molecular Medicine

Korean Society for Biochemistry and Molecular Biongy (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Kurarinone promotes TRAIL-induced apoptosis by inhibiting NF-${\kappa}B$-dependent cFLIP expression in HeLa cells

  • Seo, Ok-Won (Vascular Homeostasis Laboratory, Departments of Molecular and Cellular Biochemistry and Institute of Medical Sciences, School of Medicine, Kangwon National University) ;
  • Kim, Jung Hwan (Department of Rehabilitation Medicine, School of Medicine, Kangwon National University and Hospital) ;
  • Lee, Kwang-Soon (Vascular Homeostasis Laboratory, Departments of Molecular and Cellular Biochemistry and Institute of Medical Sciences, School of Medicine, Kangwon National University) ;
  • Lee, Kyu-Sun (Vascular Homeostasis Laboratory, Departments of Molecular and Cellular Biochemistry and Institute of Medical Sciences, School of Medicine, Kangwon National University) ;
  • Kim, Ji-Hee (Vascular Homeostasis Laboratory, Departments of Molecular and Cellular Biochemistry and Institute of Medical Sciences, School of Medicine, Kangwon National University) ;
  • Won, Moo-Ho (Department of Neurobiology, School of Medicine, Kangwon National University) ;
  • Ha, Kwon-Soo (Vascular Homeostasis Laboratory, Departments of Molecular and Cellular Biochemistry and Institute of Medical Sciences, School of Medicine, Kangwon National University) ;
  • Kwon, Young-Guen (Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University) ;
  • Kim, Young-Myeong (Vascular Homeostasis Laboratory, Departments of Molecular and Cellular Biochemistry and Institute of Medical Sciences, School of Medicine, Kangwon National University)
  • Accepted : 2012.08.27
  • Published : 2012.11.30
⟨ Previous Next ⟩

Abstract

This study was designed to investigate the effects of the prenylated flavonoid kurarinone on TNF-related apoptosis inducing ligand (TRAIL)-induced apoptosis and its underlying mechanism. A low dose of kurarinone had no significant effect on apoptosis, but this compound markedly promoted tumor cell death through elevation of Bid cleavage, cytochrome c release release and caspase activation in HeLa cells treated with TRAIL. Caspase inhibitors inhibited kurarinone-mediated cell death, which indicates that the cytotoxic effect of this compound is mediated by caspase-dependent apoptosis. The cytotoxic effect of kurarinone was not associated with expression levels of Bcl-2 and IAP family proteins, such as Bcl-2, Bcl-$x_L$, Bid, Bad, Bax, XIAP, cIAP-1 and cIAP-2. In addition, this compound did not regulate the death-inducing receptors DR4 and DR5. On the other hand, kurarinone significantly inhibited TRAIL-induced IKK activation, $I{\kappa}B$ degradation and nuclear translocation of NF-${\kappa}B$, as well as effectively suppressed cellular FLICE-inhibitory protein long form ($cFLIP_L$) expression. The synergistic effects of kurarinone on TRAIL-induced apoptosis were mimicked when kurarinone was replaced by the NF-${\kappa}B$ inhibitor withaferin A or following siRNA-mediated knockdown of $cFLIP_L$. Moreover, cFLIP overexpression effectively antagonized kurarinone-mediated TRAIL sensitization. These data suggest that kurarinone sensitizes TRAIL-induced tumor cell apoptosis via suppression of NF-${\kappa}B$-dependent cFLIP expression, indicating that this compound can be used as an anti-tumor agent in combination with TRAIL.

Keywords

Acknowledgement

Supported by : National Research Foundation of Korea (NRF)

References

  1. Benayoun B, Baghdiguian S, Lajmanovich A, Bartoli M, Daniele N, Gicquel E, Bourg N, Raynaud F, Pasquier MA, Suel L, Lochmuller H, Lefranc G, Richard I. $NF-{\kappa}B$-dependent expression of the antiapoptotic factor c-FLIP is regulated by calpain 3, the protein involved in limb-girdle muscular dystrophy type 2A. FASEB J 2008;22:1521-9 https://doi.org/10.1096/fj.07-8701com
  2. Berghe WV, De Naeyer A, Dijsselbloem N, David JP, De Keukeleire D, Haegeman G. Attenuation of ERK/RSK2- driven $NF{\kappa}B$ gene expression and cancer cell proliferation by kurarinone, a lavandulyl flavanone isolated from Sophora flavescens ait. roots. Endocr Metab Immune Disord Drug Targets 2011;11:247-61 https://doi.org/10.2174/187153011796429790
  3. Budd RC, Yeh WC, Tschopp J. cFLIP regulation of lymphocyte activation and development. Nat Rev Immunol 2006;6:196-204 https://doi.org/10.1038/nri1787
  4. Butcher BA, Kim L, Johnson PF, Denkers EY. Toxoplasma gondii tachyzoites inhibit proinflammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription factor NF-${\kappa}B$. J Immunol 2001;167: 2193-201 https://doi.org/10.4049/jimmunol.167.4.2193
  5. Cho YL, Lee KS, Lee SJ, Namkoong S, Kim YM, Lee H, Ha KS, Han JA, Kwon YG. Amiloride potentiates TRAIL-induced tumor cell apoptosis by intracellular acidification-dependent Akt inactivation. Biochem Biophys Res Commun 2005;326: 752-8 https://doi.org/10.1016/j.bbrc.2004.11.109
  6. Clem RJ, Cheng EH, Karp CL, Kirsch DG, Ueno K, Takahashi A, Kastan MB, Griffin DE, Earnshaw WC, Veliuona MA, Hardwick JM. Modulation of cell death by $Bcl-_{xL}$ through caspase interaction. Proc Natl Acad Sci USA 1998;95:554-9 https://doi.org/10.1073/pnas.95.2.554
  7. De Naeyer A, Vanden Berghe W, Pocock V, Milligan S, Haegeman G, De Keukeleire D. Estrogenic and anticarcinogenic properties of kurarinone, a lavandulyl flavanone from the roots of Sophora flavescens. J Nat Prod 2004;67: 1829-32 https://doi.org/10.1021/np040069a
  8. De Naeyer A, Vanden Berghe W, Pocock V, Milligan S, Haegeman G, De Keukeleire D. Estrogenic and anticarcinogenic properties of kurarinone, a lavandulyl flavanone from the roots of Sophora flavescens. J Nat Prod 2004;67: 1829-32 https://doi.org/10.1021/np040069a
  9. Fulda S, Vucic D. Targeting IAP proteins for therapeutic intervention in cancer. Nat Rev Drug Discov 2012;11:109-24 https://doi.org/10.1038/nrd3627
  10. Gill C, Dowling C, O'Neill AJ, Watson RW. Effects of cIAP-1, cIAP-2 and XIAP triple knockdown on prostate cancer cell susceptibility to apoptosis, cell survival and proliferation. Mol Cancer 2009;8:39
  11. Griffith TS, Kucaba TA, O'Donnell MA, Burns J, Benetatos C, McKinlay MA, Condon S, Chunduru S. Sensitization of human bladder tumor cells to TNF-related apoptosisinducing ligand (TRAIL)-induced apoptosis with a small molecule IAP antagonist. Apoptosis 2011;16:13-26 https://doi.org/10.1007/s10495-010-0535-3
  12. Gupta SC, Reuter S, Phromnoi K, Park B, Hema PS, Nair M, Aggarwal BB. Nimbolide sensitizes human colon cancer cells to TRAIL through reactive oxygen species- and ERKdependent up-regulation of death receptors, p53, and Bax. J Biol Chem 2011;286:1134-46
  13. Han J, Sun M, Cui Y, Wang T, Zhang W, Guo M, Zhou Y, Liu W, Zhang M, Duan J, Xiong S, Yao M, Yan X. Kushen flavonoids induce apoptosis in tumor cells by inhibition of $NF-{\kappa}B$ activation and multiple receptor tyrosine kinase activities. Phytother Res 2007;21:262-8 https://doi.org/10.1002/ptr.2065
  14. Han JM, Jin YY, Kim HY, Park KH, Lee WS, Jeong TS. Lavandulyl flavonoids from Sophora flavescens suppress lipopolysaccharide-induced activation of nuclear factor-${\kappa}B$ and mitogen-activated protein kinases in RAW264.7 cells. Biol Pharm Bull 2010;33:1019-23 https://doi.org/10.1248/bpb.33.1019
  15. Jane EP, Premkumar DR, Pollack IF. Bortezomib sensitizes malignant human glioma cells to TRAIL, mediated by inhibition of the $NF-{\kappa}B$ signaling pathway. Mol Cancer Ther 2011;10:198-208 https://doi.org/10.1158/1535-7163.MCT-10-0725
  16. Jani TS, DeVecchio J, Mazumdar T, Agyeman A, Houghton JA. Inhibition of $NF-{\kappa}B$ signaling by quinacrine is cytotoxic to human colon carcinoma cell lines and is synergistic in combination with tumor necrosis factor-related apoptosisinducing ligand (TRAIL) or oxaliplatin. J Biol Chem 2010;285: 19162-72 https://doi.org/10.1074/jbc.M109.091645
  17. Jeremias I, Debatin KM. TRAIL induces apoptosis and activation of $NF{\kappa}B$. Eur Cytokine Netw 1998;9:687-8
  18. Jung YH, Lim EJ, Heo J, Kwon TK, Kim YH. Tunicamycin sensitizes human prostate cells to TRAIL-induced apoptosis by upregulation of TRAIL receptors and downregulation of cIAP2. Int J Oncol 2012;40:1941-8
  19. Kaileh M, Vanden Berghe W, Heyerick A, Horion J, Piette J, Libert C, De Keukeleire D, Essawi T, Haegeman G. Withaferin a strongly elicits $I{\kappa}B$ kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity. J Biol Chem 2007;282:4253-64 https://doi.org/10.1074/jbc.M606728200
  20. Kang TH, Jeong SJ, Ko WG, Kim NY, Lee BH, Inagaki M, Miyamoto T, Higuchi R, Kim YC. Cytotoxic lavandulyl flavanones from Sophora flavescens. J Nat Prod 2000;63: 680-1 https://doi.org/10.1021/np990567x
  21. Kang YC, Kim KM, Lee KS, Namkoong S, Lee SJ, Han JA, Jeoung D, Ha KS, Kwon YG, Kim YM. Serum bioactive lysophospholipids prevent TRAIL-induced apoptosis via PI3K/Akt-dependent cFLIP expression and Bad phosphorylation. Cell Death Differ 2004;11:1287-98 https://doi.org/10.1038/sj.cdd.4401489
  22. Kang YJ, Kim IY, Kim EH, Yoon MJ, Kim SU, Kwon TK, Choi KS. Paxilline enhances TRAIL-mediated apoptosis of glioma cells via modulation of c-FLIP, survivin and DR5. Exp Mol Med 2011;43:24-34 https://doi.org/10.3858/emm.2011.43.1.003
  23. Kavuri SM, Geserick P, Berg D, Dimitrova DP, Feoktistova M, Siegmund D, Gollnick H, Neumann M, Wajant H, Leverkus M. Cellular FLICE-inhibitory protein (cFLIP) isoforms block CD95- and TRAIL death receptor-induced gene induction irrespective of processing of caspase-8 or cFLIP in the death-inducing signaling complex. J Biol Chem 2011;286: 16631-46 https://doi.org/10.1074/jbc.M110.148585
  24. Kim YM, de Vera ME, Watkins SC, Billiar TR. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression. J Biol Chem 1997;272:1402-11 https://doi.org/10.1074/jbc.272.2.1402
  25. Kim YM, Kim TH, Chung HT, Talanian RV, Yin XM, Billiar TR. Nitric oxide prevents tumor necrosis factor alpha-induced rat hepatocyte apoptosis by the interruption of mitochondrial apoptotic signaling through S-nitrosylation of caspase-8. Hepatology 2000;32:770-8 https://doi.org/10.1053/jhep.2000.18291
  26. Kim H, Kim EH, Eom YW, Kim WH, Kwon TK, Lee SJ, Choi KS. Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5. Cancer Res 2006; 66:1740-50 https://doi.org/10.1158/0008-5472.CAN-05-1568
  27. Lee TJ, Um HJ, Min do S, Park JW, Choi KS, Kwon TK. Withaferin A sensitizes TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Free Radic Biol Med 2009;46:1639-49 https://doi.org/10.1016/j.freeradbiomed.2009.03.022
  28. Martinou JC, Youle RJ. Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell 2011; 21:92-101 https://doi.org/10.1016/j.devcel.2011.06.017
  29. Matsuda F, Inoue N, Goto Y, Maeda A, Cheng Y, Sakamaki K, Manabe N. cFLIP regulates death receptor-mediated apoptosis in an ovarian granulosa cell line by inhibiting procaspase-8 cleavage. J Reprod Dev 2008;54:314-20 https://doi.org/10.1262/jrd.20051
  30. Moon MH, Jeong JK, Seo JS, Seol JW, Lee YJ, Xue M, Jackson CJ, Park SY. Bisphosphonate enhances TRAIL sensitivity to human osteosarcoma cells via death receptor 5 upregulation. Exp Mol Med 2011;43:138-45 https://doi.org/10.3858/emm.2011.43.3.016
  31. Murtaza I, Saleem M, Adhami VM, Hafeez BB, Mukhtar H. Suppression of cFLIP by lupeol, a dietary triterpene, is sufficient to overcome resistance to TRAIL-mediated apoptosis in chemoresistant human pancreatic cancer cells. Cancer Res 2009;69:1156-65
  32. Neuzil J, Swettenham E, Gellert N. Sensitization of mesothelioma to TRAIL apoptosis by inhibition of histone deacetylase: role of Bcl-xL down-regulation. Biochem Biophys Res Commun 2004;314:186-91 https://doi.org/10.1016/j.bbrc.2003.12.074
  33. Pan G, Ni J, Wei YF, Yu G, Gentz R, Dixit VM. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 1997;277:815-8 https://doi.org/10.1126/science.277.5327.815
  34. Plantivaux A, Szegezdi E, Samali A, Egan L. Is there a role for nuclear factor kappaB in tumor necrosis factor-related apoptosis-inducing ligand resistance? Ann NY Acad Sci 2009;1171:38-49 https://doi.org/10.1111/j.1749-6632.2009.04725.x
  35. Rae C, Langa S, Tucker SJ, MacEwan DJ. Elevated $NF-{\kappa}B$ responses and FLIP levels in leukemic but not normal lymphocytes: reduction by salicylate allows TNF-induced apoptosis. Proc Natl Acad Sci USA 2007;104:12790-5 https://doi.org/10.1073/pnas.0701437104
  36. Ravi R, Bedi A, Fuchs EJ, Bedi A. CD95 (Fas)-induced caspase-mediated proteolysis of $NF-{\kappa}B$. Cancer Res 1998; 58:882-6
  37. Riedl SJ, Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 2004;5:897-907 https://doi.org/10.1038/nrm1496
  38. Romagnoli M, Desplanques G, Maiga S, Legouill S, Dreano M, Bataille R, Barille-Nion S. Canonical nuclear factor kappaB pathway inhibition blocks myeloma cell growth and induces apoptosis in strong synergy with TRAIL. Clin Cancer Res 2007;13:6010-8 https://doi.org/10.1158/1078-0432.CCR-07-0140
  39. Seol JW, Lee YJ, Kang HS, Kim IS, Kim NS, Kwak YG, Kim TH, Seol DW, Park SY. Wortmannin elevates tumor necrosis factor-related apoptosis-inducing ligand sensitivity in LNCaP cells through down-regulation of IAP-2 protein. Exp Oncol 2005;27:120-4
  40. Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 2008;9: 231-41 https://doi.org/10.1038/nrm2312
  41. Traenckner EB, Pahl HL, Henkel T, Schmidt KN, Wilk S, Baeuerle PA. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I${\kappa}B$-alpha proteolysis and $NF-{\kappa}B$ activation in response to diverse stimuli. EMBO J 1995;14: 2876-83
  42. Walczak H, Bouchon A, Stahl H, Krammer PH. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells. Cancer Res 2000;60: 3051-7
  43. Wang MJ, Liu S, Liu Y, Zheng D. Actinomycin D enhances TRAIL-induced caspase-dependent and -independent apoptosis in SH-SY5Y neuroblastoma cells. Neurosci Res 2007;59:40-6 https://doi.org/10.1016/j.neures.2007.05.010

Cited by

  1. Cordycepin increases sensitivity of Hep3B human hepatocellular carcinoma cells to TRAIL-mediated apoptosis by inactivating the JNK signaling pathway vol.30, pp.3, 2012, https://doi.org/10.3892/or.2013.2589
  2. Embelin Sensitizes Acute Myeloid Leukemia Cells to TRAIL through XIAP Inhibition and NF-κB Inactivation vol.71, pp.1, 2012, https://doi.org/10.1007/s12013-014-0197-9
  3. Embelin Sensitizes Acute Myeloid Leukemia Cells to TRAIL through XIAP Inhibition and NF-κB Inactivation vol.71, pp.1, 2012, https://doi.org/10.1007/s12013-014-0197-9
  4. The Histone Deacetylase Inhibitor Trichostatin A Sensitizes Human Renal Carcinoma Cells to TRAIL-Induced Apoptosis through Down-Regulation of c-FLIPL vol.23, pp.1, 2012, https://doi.org/10.4062/biomolther.2014.092
  5. Kurarinone Synergizes TRAIL-Induced Apoptosis in Gastric Cancer Cells vol.72, pp.1, 2012, https://doi.org/10.1007/s12013-014-0444-0
  6. Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy vol.240, pp.6, 2012, https://doi.org/10.1177/1535370215579167
  7. Decursin enhances TRAIL‐induced apoptosis through oxidative stress mediated‐ endoplasmic reticulum stress signalling in non‐small cell lung cancers vol.173, pp.6, 2012, https://doi.org/10.1111/bph.13408
  8. Tanshinone IIA induces TRAIL sensitization of human lung cancer cells through selective ER stress induction vol.48, pp.5, 2012, https://doi.org/10.3892/ijo.2016.3441
  9. 인체 방광암세포에서 histone deacetylase 억제제인 sodium butyrate이 TRAIL에 의한 apoptosis 유도에 미치는 영향 vol.26, pp.4, 2016, https://doi.org/10.5352/jls.2016.26.4.431
  10. Urinary Bladder-Relaxant Effect of Kurarinone Depending on Potentiation of Large-Conductance Ca2+-Activated K+ Channels vol.90, pp.2, 2012, https://doi.org/10.1124/mol.115.102939
  11. Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs) vol.22, pp.7, 2017, https://doi.org/10.1007/s10495-017-1375-1
  12. TNF-related apoptosis-inducing ligand (TRAIL) as the potential therapeutic target in hematological malignancies vol.98, pp.None, 2012, https://doi.org/10.1016/j.biopha.2017.12.082
  13. ShDcR3 sensitizes TRAIL-resistant HCC cells by inducing caspase-dependent apoptosis while suppressing NF-κB dependent cFLIP L expression vol.13, pp.2, 2012, https://doi.org/10.1371/journal.pone.0191545
  14. HepG2 세포에서 tert-butyl hydroperoxide로 유도된 간독성에 대한 kurarinone의 세포 보호 효과 vol.26, pp.3, 2012, https://doi.org/10.14374/hfs.2018.26.3.251
  15. Down‐regulation of intracellular anti‐apoptotic proteins, particularly c‐FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL vol.233, pp.10, 2012, https://doi.org/10.1002/jcp.26585
  16. Synergistic Anti-tumour Effects of Quercetin and Oncolytic Adenovirus expressing TRAIL in Human Hepatocellular Carcinoma vol.8, pp.None, 2018, https://doi.org/10.1038/s41598-018-20213-7
  17. Kurarinone from Sophora Flavescens Roots Triggers ATF4 Activation and Cytostatic Effects Through PERK Phosphorylation vol.24, pp.17, 2012, https://doi.org/10.3390/molecules24173110
  18. Kurarinone Inhibits HCoV-OC43 Infection by Impairing the Virus-Induced Autophagic Flux in MRC-5 Human Lung Cells vol.9, pp.7, 2012, https://doi.org/10.3390/jcm9072230
  19. YM155 sensitizes HeLa cells to TRAIL-mediated apoptosis via cFLIP and survivin downregulation vol.20, pp.4, 2020, https://doi.org/10.3892/ol.2020.11933